Entera Health, Inc   Report issue

For profit Phase 2
Founded: Boone IA United States (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2013
NCT02067377
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Entera Health, Inc

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 2)

Multiple Myeloma (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 5